Data compiled by Redley Lamar · ChainSifter Intelligence
3Suppliers
4Customers
3Debt Items
11Related Chains
Source-Backed Evidence Depth
Emergent BioSolutions Inc. (EBS) is shown with relationship data already present in ChainSifter's database. Counts below come from stored supply-chain records and filing/source URLs where available; missing source URLs are not filled in or estimated.
11Total relationships
2Distinct source URLs
5High confidence
0.793Average confidence
2026-10-28Latest database update
ChainSifter does not infer unreported suppliers, customers, ownership, acquisitions, debt exposure, revenue dependency, or future supply-chain events on this public page.
Emergent BioSolutions Inc. Suppliers
Ticker
Name
Confidence
Evidence
OHA-AGENCY-LLC
OHA-AGENCY-LLC
90%
Prior Term Loan Agreement with OHA Agency LLC, as administrative agent, and the lenders from time to time party thereto
Reciprocal relationship from SABS graph: Reciprocal relationship from EBS graph: Reciprocal relationship from SABS graph: gal activity. Misconduct by these parties could include intentional, reckless…
Reciprocal relationship from SABSW graph: Reciprocal relationship from EBS graph: Reciprocal relationship from SABSW graph: Reciprocal relationship from EBS graph: Reciprocal relationship from SABSW …
Reciprocal relationship from SABS graph: Reciprocal relationship from EBS graph: Reciprocal relationship from SABS graph: Reciprocal relationship from EBS graph: Reciprocal relationship from SABS gra…
Reciprocal relationship from SABSW graph: uld result in reduced production yields, lot failures, product defects, product delays, product recalls, product liability claims and other supply disruption…
Reciprocal relationship from VXRT graph: Reciprocal relationship from EBS graph: Reciprocal relationship from VXRT graph: irements relating to the organization of personnel, buildings and facilities,…
HIKMA-PHARMACEUTICALS-INC
HIKMA-PHARMACEUTICALS-INC
62%
or implied by the forward-looking statements contained in the following discussion and analysis. BUSINESS OVERVIEW Emergent BioSolutions Inc. (“Emergent,” the “Company,” “we,” “us,” and “our”) is a g…
Emergent BioSolutions Inc. Debt Obligations
Instrument
Description
Confidence
Evidence
EBS-DEBT
Debt stack $581.8M
90%
Market cache reports total debt of $581.8M.
EBS-DEBT-9208
Xbrl Convertible
90%
xbrl convertible detail from xbrl 2018-12-31.
EBS-DEBT-9207
Warrants outstanding: 5500000
90%
xbrl warrant detail from xbrl 2025-12-31.
Emergent BioSolutions Inc. Acquisitions
No acquisitions on recordNo completed or pending acquisitions found in our database for Emergent BioSolutions Inc..
Emergent BioSolutions Inc. Ownership
Holder
Name
Confidence
Evidence
EBS-OWNER-VANGUARD-CAPITAL-MANAGEMENT-LLC
VANGUARD CAPITAL MANAGEMENT LLC
90%
13F overlay lists VANGUARD CAPITAL MANAGEMENT LLC as top holder; 192 tracked holders.
Emergent BioSolutions Inc. Extended Supply Chain Network
